Eden Research plc Logo

Eden Research plc

EDEN.L

(0.8)
Stock Price

3,50 GBp

-54.65% ROA

-70.32% ROE

-2.91x PER

Market Cap.

21.867.473,00 GBp

1.7% DER

0% Yield

-203.45% NPM

Eden Research plc Stock Analysis

Eden Research plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Eden Research plc Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (3%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (1.73x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

3 ROE

Negative ROE (-19.08%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-50.26%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Eden Research plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Eden Research plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Sell
4 Stoch RSI Buy

Eden Research plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Eden Research plc Revenue
Year Revenue Growth
2009 193.000
2010 172.000 -12.21%
2011 91.000 -89.01%
2012 43.590 -108.76%
2013 80.223 45.66%
2014 99.855 19.66%
2015 883.312 88.7%
2016 391.958 -125.36%
2017 1.877.187 79.12%
2018 2.774.272 32.34%
2019 2.048.075 -35.46%
2019 1.825.501 -12.19%
2020 1.368.988 -33.35%
2021 1.228.580 -11.43%
2022 1.827.171 32.76%
2023 8.198.624 77.71%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Eden Research plc Research and Development Expenses
Year Research and Development Expenses Growth
2009 35.000
2010 25.000 -40%
2011 0 0%
2012 0 0%
2013 154.511 100%
2014 179.824 14.08%
2015 200.093 10.13%
2016 225.141 11.13%
2017 290.276 22.44%
2018 183.018 -58.61%
2019 0 0%
2019 231.077 100%
2020 315.192 26.69%
2021 214.682 -46.82%
2022 284.174 24.45%
2023 640.996 55.67%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Eden Research plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2009 0
2010 0 0%
2011 0 0%
2012 890.378 100%
2013 1.034.878 13.96%
2014 1.210.457 14.51%
2015 1.267.930 4.53%
2016 1.439.706 11.93%
2017 1.431.787 -0.55%
2018 1.518.914 5.74%
2019 1.535.450 1.08%
2019 2.032.182 24.44%
2020 2.202.581 7.74%
2021 2.694.290 18.25%
2022 2.749.240 2%
2023 6.988.368 60.66%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Eden Research plc EBITDA
Year EBITDA Growth
2009 -984.000
2010 -1.673.000 41.18%
2011 -1.337.000 -25.13%
2012 -1.602.226 16.55%
2013 -997.905 -60.56%
2014 -1.290.426 22.67%
2015 -683.419 -88.82%
2016 -1.431.156 52.25%
2017 -891.366 -60.56%
2018 -250.183 -256.29%
2019 -964.532 74.06%
2019 -838.810 -14.99%
2020 -1.620.440 48.24%
2021 -2.618.310 38.11%
2022 -1.879.590 -39.3%
2023 -2.381.888 21.09%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Eden Research plc Gross Profit
Year Gross Profit Growth
2009 193.000
2010 172.000 -12.21%
2011 91.000 -89.01%
2012 43.590 -108.76%
2013 80.223 45.66%
2014 99.855 19.66%
2015 784.604 87.27%
2016 363.398 -115.91%
2017 857.907 57.64%
2018 1.537.121 44.19%
2019 883.861 -73.91%
2019 861.784 -2.56%
2020 9.631 -8848.02%
2021 28.320 65.99%
2022 207.142 86.33%
2023 5.333.784 96.12%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Eden Research plc Net Profit
Year Net Profit Growth
2009 -1.727.000
2010 -3.251.000 46.88%
2011 -3.284.000 1%
2012 -2.317.134 -41.73%
2013 -1.587.909 -45.92%
2014 -2.969.468 46.53%
2015 -1.157.103 -156.63%
2016 -1.831.092 36.81%
2017 -639.093 -186.51%
2018 -334.951 -90.8%
2019 -1.132.337 70.42%
2019 -1.144.703 1.08%
2020 -2.270.347 49.58%
2021 -2.788.973 18.6%
2022 -2.237.262 -24.66%
2023 -2.428.220 7.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Eden Research plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2009 0
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Eden Research plc Free Cashflow
Year Free Cashflow Growth
2009 -635.000
2010 -1.856.000 65.79%
2011 -2.936.000 36.78%
2012 -1.732.737 -69.44%
2013 -1.436.696 -20.61%
2014 -1.396.484 -2.88%
2015 -236.867 -489.56%
2016 -1.043.774 77.31%
2017 -242.038 -331.24%
2018 -1.214.296 80.07%
2019 -481.989 -151.93%
2019 -1.927.149 74.99%
2020 -2.917.354 33.94%
2021 -3.344.754 12.78%
2022 -1.737.286 -92.53%
2023 -777.211 -123.53%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Eden Research plc Operating Cashflow
Year Operating Cashflow Growth
2009 -432.000
2010 -1.751.000 75.33%
2011 -2.628.000 33.37%
2012 -1.621.505 -62.07%
2013 -1.245.977 -30.14%
2014 -930.295 -33.93%
2015 -104.861 -787.17%
2016 -805.789 86.99%
2017 230.041 450.28%
2018 -701.678 132.78%
2019 -253.527 -176.77%
2019 -1.013.299 74.98%
2020 -1.015.309 0.2%
2021 -1.618.558 37.27%
2022 -683.095 -136.94%
2023 -676.695 -0.95%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Eden Research plc Capital Expenditure
Year Capital Expenditure Growth
2009 203.000
2010 105.000 -93.33%
2011 308.000 65.91%
2012 111.232 -176.9%
2013 190.719 41.68%
2014 466.189 59.09%
2015 132.006 -253.16%
2016 237.985 44.53%
2017 472.079 49.59%
2018 512.618 7.91%
2019 228.463 -124.38%
2019 913.850 75%
2020 1.902.045 51.95%
2021 1.726.196 -10.19%
2022 1.054.191 -63.75%
2023 100.516 -948.78%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Eden Research plc Equity
Year Equity Growth
2009 4.756.000
2010 2.603.000 -82.71%
2011 5.386.000 51.67%
2012 5.508.022 2.22%
2013 5.679.608 3.02%
2014 5.942.952 4.43%
2015 5.926.899 -0.27%
2016 6.763.155 12.36%
2017 8.513.915 20.56%
2018 8.277.303 -2.86%
2019 7.347.674 -12.65%
2020 14.928.949 50.78%
2021 12.829.475 -16.36%
2022 10.742.918 -19.42%
2023 13.545.797 20.69%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Eden Research plc Assets
Year Assets Growth
2009 8.875.000
2010 8.279.000 -7.2%
2011 8.294.000 0.18%
2012 7.602.663 -9.09%
2013 6.533.701 -16.36%
2014 6.401.255 -2.07%
2015 6.679.451 4.16%
2016 7.795.903 14.32%
2017 10.585.878 26.36%
2018 9.220.169 -14.81%
2019 8.864.769 -4.01%
2020 16.924.364 47.62%
2021 15.027.085 -12.63%
2022 12.911.582 -16.38%
2023 16.594.719 22.19%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Eden Research plc Liabilities
Year Liabilities Growth
2009 4.119.000
2010 5.676.000 27.43%
2011 2.908.000 -95.19%
2012 2.094.641 -38.83%
2013 854.093 -145.25%
2014 458.303 -86.36%
2015 752.552 39.1%
2016 1.032.748 27.13%
2017 2.071.963 50.16%
2018 942.866 -119.75%
2019 1.517.095 37.85%
2020 1.995.415 23.97%
2021 2.197.610 9.2%
2022 2.168.664 -1.33%
2023 3.048.922 28.87%

Eden Research plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.01
Price to Earning Ratio
-2.91x
Price To Sales Ratio
6.85x
POCF Ratio
-11.15
PFCF Ratio
-9.83
Price to Book Ratio
1.4
EV to Sales
4.6
EV Over EBITDA
-10.25
EV to Operating CashFlow
-8.66
EV to FreeCashFlow
-6.6
Earnings Yield
-0.34
FreeCashFlow Yield
-0.1
Market Cap
0,02 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.1
Graham NetNet
0.01

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.26
ROE
-0.7
Return On Assets
-0.39
Return On Capital Employed
-0.14
Net Income per EBT
0.94
EBT Per Ebit
3.69
Ebit per Revenue
-0.58
Effective Tax Rate
0.03

Margins

Sales, General, & Administrative to Revenue
0.94
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0.07
Gross Profit Margin
0.44
Operating Profit Margin
-0.58
Pretax Profit Margin
-2.16
Net Profit Margin
-2.03

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
-0.31
Capex to Revenue
0.17
Capex to Depreciation
1.05
Return on Invested Capital
-0.13
Return on Tangible Assets
-0.55
Days Sales Outstanding
297.81
Days Payables Outstanding
392.15
Days of Inventory on Hand
196.43
Receivables Turnover
1.23
Payables Turnover
0.93
Inventory Turnover
1.86
Capex per Share
0

Balance Sheet

Cash per Share
0,02
Book Value per Share
0,03
Tangible Book Value per Share
0.02
Shareholders Equity per Share
0.03
Interest Debt per Share
0
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
5.02
Current Ratio
3.76
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
13335520
Working Capital
0,01 Bil.
Intangibles to Total Assets
0.28
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
807973
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Eden Research plc Dividends
Year Dividends Growth

Eden Research plc Profile

About Eden Research plc

Eden Research plc offers sustainable solutions for crop protection, animal health, and consumer products in the United Kingdom and rest of Europe. The company provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. It also offers animal health products, such as companion animal, bio-control, parasite treatments, and insect spray products. In addition, the company provides human health products comprising head-lice treatment products, fragrances, deodorants, wound-care products, food flavorings, odor neutralizers, and active ingredient supply/delivery products. The company was incorporated in 1995 and is headquartered in Abingdon, the United Kingdom.

CEO
Mr. Sean Michael Smith
Employee
19
Address
67C Innovation Drive
Abingdon, OX14 4RQ

Eden Research plc Executives & BODs

Eden Research plc Executives & BODs
# Name Age
1 Mr. Sean Michael Smith
Chief Executive Officer & Executive Director
70
2 Mr. Alexander John Abrey
Chief Financial Officer, Secretary & Executive Director
70

Eden Research plc Competitors